Vimarsana
Biggest News Aggregation in the World

First Wave Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from First Wave Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In First Wave Bio Today - Breaking & Trending Today

First Wave BioPharma Announces Exercise of Warrants and - Vimarsana News

First Wave BioPharma Announces Exercise of Warrants and

BOCA RATON, Fla., Dec. 27, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (“First Wave BioPharma” or the “Company”) (NASDAQ: FWBI), a clinical-stage...

First Wave BioPharma Announces Streamlining of Clinical - Vimarsana News

First Wave BioPharma Announces Streamlining of Clinical

First Wave BioPharma to advance GI development pipeline with the expected addition of Phase 3 Latiglutenase celiac disease program and Phase 2 clinical...

First Wave BioPharma Announces Streamlining of Clinical Pipeline with Non-Binding Term Sheet to Sell Niclosamide IBD Program - Vimarsana News

First Wave BioPharma Announces Streamlining of Clinical Pipeline with Non-Binding Term Sheet to Sell Niclosamide IBD Program

First Wave BioPharma to advance GI development pipeline with the expected addition of Phase 3 Latiglutenase celiac disease program and Phase 2 clinical programs built around Capeserod and AdrulipaseBOCA RATON, Fla., Dec. 27, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced

Source: yahoo.com
First Wave BioPharma Announces Exercise of Warrants and - Vimarsana News

First Wave BioPharma Announces Exercise of Warrants and

BOCA RATON, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (“First Wave BioPharma” or the “Company”) (NASDAQ: FWBI), a...

First Wave BioPharma Announces Final Patient Dosed in Phase - Vimarsana News

First Wave BioPharma Announces Final Patient Dosed in Phase

Topline data expected in July 2023...